SPY304.84+0.52 0.17%
DIA254.77+0.48 0.19%
IXIC9,520.34+30.47 0.32%

Mizuho Maintains Buy on Arcus Biosciences, Raises Price Target to $40

Mizuho maintains Arcus Biosciences (NYSE:RCUS) with a Buy and raises the price target from $22 to $40.

Benzinga · 05/14/2020 12:14

Mizuho maintains Arcus Biosciences (NYSE:RCUS) with a Buy and raises the price target from $22 to $40.